PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis

Z I Niemir1, H Stein, I L Noronha

  • 1Department of Pathology, Ruperto-Carola University, Heidelberg, Germany.

Kidney International
|November 1, 1995
PubMed

Insights

Platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) are implicated in IgA glomerulonephritis (IgA-GN). Increased PDGF expression correlates with disease severity, while TGF-beta activation appears limited, suggesting an imbalance contributing to IgA-GN progression.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunopathology

Background:

  • Platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta) are key regulators of mesangial cell proliferation and extracellular matrix production.
  • IgA glomerulonephritis (IgA-GN) is characterized by mesangial cell proliferation and matrix expansion, suggesting a role for these growth factors.

Purpose of the Study:

  • To investigate the expression and localization of PDGF and TGF-beta in renal biopsies from patients with IgA-GN.
  • To correlate growth factor expression with histological and clinical features of IgA-GN.

Main Methods:

  • Analysis of PDGF (A/B chains, beta R) and TGF-beta 1 mRNA expression using RT/PCR and in situ hybridization.
  • Immunocytochemical detection of PDGF-AB/BB, PDGF-beta R, TGF-beta isoforms, TGF-beta 1 latency associated peptide (LAP), tenascin, and decorin.
  • Correlation of growth factor expression with light microscopy and clinical data.

Main Results:

  • Increased PDGF-BB/PDGF-beta R mRNA and protein expression were observed in IgA-GN biopsies compared to controls, correlating with glomerular proliferation and interstitial fibrosis.
  • Abundant TGF-beta 1 mRNA was detected in all IgA-GN biopsies, but TGF-beta 1 protein expression was variable and less prominent, particularly in advanced lesions.
  • Limited TGF-beta 1 activation was suggested by higher TGF-beta 1 LAP staining intensity compared to TGF-beta 1, and decreased tenascin in sclerotic lesions.

Conclusions:

  • PDGF expression is up-regulated in IgA-GN and correlates with proliferative activity, suggesting it as a potential marker of disease activity.
  • A discordance between TGF-beta 1 mRNA and protein expression, along with limited activation, indicates a potential imbalance in TGF-beta signaling.
  • Resident glomerular cells are the primary source of growth factor production in IgA-GN, and an imbalance between PDGF and TGF-beta may drive disease progression.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.6K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.2K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
17